Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(46 sites)

China

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui

The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui

Beijing Chao-Yang Hospital，Capital Medical University, Beijing, Beijing Municipality

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality

Peking University Third Hospital, Beijing, Beijing Municipality